Orchid Asia's Portfolio Company, Wuyi Pharmaceutical, Achieves a Auccessful IPO Listing on the Hong Kong Stock Exchange

Orchid Asia's Portfolio Company, Wuyi Pharmaceutical, Achieves a Auccessful IPO Listing on the Hong Kong Stock Exchange

February 01, 2007

Orchid Asia Led Transaction of US$18 Million in Wuyi Prior
to IPO


    HONG KONG, Feb. 1 /Xinhua-PRNewswire/ -- Orchid Asia, a
leading private equity group focused on Chinese companies,
announced that one of its portfolio companies, Wuyi
International Pharmaceutical Company Limited (HKEX: 1889),
has successfully achieved an IPO listing on the Main Board
of Hong Kong Stock Exchange on Feb 1, 2007.  Wuyi is a
pharmaceutical group focused on manufacturing, marketing,
and selling branded prescription with over-the-counter
western pharmaceuticals and modern Chinese medicine
products.  Orchid Asia led the private equity transaction
in investing US$18 million in Wuyi in 2006. Mr. Gabriel Li,
Managing Director of Orchid Asia says, "We are very
pleased to be a financial partner and strategic partner to
Wuyi."

    Orchid Asia has been investing in China for over 10
years and is one of the first international private equity
investors in China. Throughout the past decade, Orchid Asia
has invested in numerous successful companies in China
including Ctrip International (listed on the Nasdaq),
Eachnet (sold to eBay), Zhaopin (a leading online
recruitment firm in China), Sport100 (the leading
multibrand sporting goods retail chain in China), Longsheng
Tea (the leading Puer tea company in China) and many other
leading companies. Orchid Asia currently manages over
US$250 million of capital commitments and has offices in
Hong Kong, Shanghai, Guangzhou and San Francisco. The
investment team consists of professionals with different
backgrounds from Goldman Sachs, Carlyle, Lehman Brothers,
McKinsey, GE, and others. 



    For more information, please contact:
	
    Hong Kong 	
     Vivian Wong	
     Tel:   [phone]
     Email: [e-mail]

    Shanghai	
     Bei Wang 	
     Tel:   [phone]
     Email: [e-mail]


SOURCE  Orchid Asia